Author: Madrid. Comunidad. Consejería de Economía e Innovación Tecnológica
Publisher:
ISBN:
Category :
Languages : es
Pages : 101

Get Book Here

Book Description

Author:
Publisher:
ISBN: 9788445123706
Category :
Languages : es
Pages : 101

Get Book Here

Book Description

Author: OECD
Publisher: OECD Publishing
ISBN: 9264038485
Category :
Languages : en
Pages : 262

Get Book Here

Book Description
Madrid has experienced impressive dynamic economic growth in recent years, making the best of the positive business cycle in Spain. The capital region absorbs more than a half of the total FDI in Spain and has extended its economic relations with ...

Author: Juan Carlos Cubeiro
Publisher: Editorial Almuzara
ISBN: 8483561778
Category : Business & Economics
Languages : en
Pages : 185

Get Book Here

Book Description
¿Qué tienen en común el seleccionador nacional de baloncesto y el director general de Inditex? Aunque a simple vista pudiera parecer que más bien poco, un análisis más profundo revela multitud de paralelismos entre los que, quizá, el más significativo sea que ambos dirigen equipos ejerciendo (y gestionando) el liderazgo con el objetivo de alcanzar la excelencia (se refleje ésta en una cuenta de resultados o en un campeonato olímpico). Partiendo de las similitudes (y también de las diferencias) entre el ámbito del deporte de alta competición y el mundo de la alta gestión, Juan Carlos Cubeiro y Leonor Gallardo desarrollan un estudio conciso y ameno, repleto de referencias a casos reales y cercanos de deportistas de éxito (Fernando Alonso, Rafa Nadal, el Sevilla C.F., etc.) y de empresas y empresarios igualmente reconocidos (Microsoft, Inditex...) de los que extraen valiosas lecciones que se pueden aplicar en nuestro día a día en la búsqueda de esa excelencia. Descriptivo y formativo, Liderazgo, empresa y deporte, puede leerse desde el punto de vista del deportista o del gestor pues ofrece claves esenciales que permitirán tanto a uno como a otro alcanzar el oro en la gestión y obtener dividendos tangibles en el deporte.

Author: Agustí Nieto-Galan
Publisher: Cambridge University Press
ISBN: 1108482430
Category : Business & Economics
Languages : en
Pages : 311

Get Book Here

Book Description
Agust Nieto-Galan argues that chemistry in the twentieth century was deeply and profoundly political. Far from existing in a distinct public sphere, chemical knowledge was applied in ways that created strong links with industrial and military projects, and national rivalries and international endeavours, that materially shaped the living conditions of millions of citizens. It is within this framework that Nieto-Galan analyses how Spanish chemists became powerful ideological agents in different political contexts, from liberal to dictatorial regimes, throughout the century. He unveils chemists' position of power in Spain, their place in international scientific networks, and their engagement in fierce ideological battles in an age of extremes. Shared discourses between chemistry and liberalism, war, totalitarianism, religion, and diplomacy, he argues, led to advancements in both fields.

Author:
Publisher:
ISBN:
Category : Microforms
Languages : en
Pages : 798

Get Book Here

Book Description

Author: Badi H. Baltagi
Publisher: Emerald Group Publishing
ISBN: 1839095008
Category : Business & Economics
Languages : en
Pages : 164

Get Book Here

Book Description
This volume contains an Open Access Chapter - This book provides a comprehensive understanding of the sustainability of health systems in Europe. Furthermore, it includes an introduction on how EU action in supporting health- care policies in the EU Member States, both looking at implemented actions and describing current priorities for the future.

Author: Jaume Puig-Junoy
Publisher: Edward Elgar Publishing
ISBN:
Category : Business & Economics
Languages : en
Pages : 280

Get Book Here

Book Description
This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability. The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patient's benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription? Jaume Puig-Junoy has performed an invaluable task in creating a cohesive, and analytically rigorous book of specially commissioned chapters on this pertinent topic. The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries and policymakers.

Author: Organizer Committee IPAP18 – Salamanca
Publisher: Ediciones Universidad de Salamanca
ISBN: 8490129762
Category : Medical
Languages : es
Pages : 358

Get Book Here

Book Description
This book contains the summaries of the "Innovation in Pharmacy: Advances and Perspectives" that took place in Salamanca (Spain) in September 2018. The early science of chemistry and microbiology were the source of most drugs until the revolution of genetic engineering in the mid 1970s. Then biotechnology made available novel protein agents such as interferons, blood factors and monoclonal antibodies that have changed the modern pharmacy. Over the past year, a new pharmacy of oligonucleotides has emerged from the science of gene expression such as RNA splicing and RNA interference. The ability to design therapeutic agents from genomic sequences will transform treatment for many diseases. The science that created this advance and its future promise will be discussed. Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for “the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence. He works in Institute Professor Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT), Cambridge, MA, US. Este libro recoge los resúmenes de la «Innovation in Pharmacy: Advances and Perspectives» que tuvo lugar en Salamanca (España) en septiembre de 2018. La ciencia primitiva de la química y la microbiología fue la fuente de la mayoría de las drogas hasta la revolución de la ingeniería genética a mediados de la década de 1970. Luego, la biotecnología puso a disposición agentes proteínicos novedosos como interferones, factores sanguíneos y anticuerpos monoclonales que han cambiado la farmacia moderna. Durante el año pasado, surgió una nueva farmacia de oligonucleótidos a partir de la ciencia de la expresión génica, como el empalme de ARN y la interferencia de ARN. La capacidad de diseñar agentes terapéuticos a partir de secuencias genómicas transformará el tratamiento de muchas enfermedades. La ciencia que creó este avance y su promesa futura será discutida. Phillip Allen Sharp es un genetista y biólogo molecular estadounidense que co-descubrió el empalme de ARN. Compartió el Premio Nobel de 1993 en Fisiología o Medicina con Richard J. Roberts por "el descubrimiento de que los genes en eucariotas no son cadenas contiguas, sino que contienen intrones, y que el empalme del ARN mensajero para eliminar esos intrones puede ocurrir de diferentes maneras, produciendo diferentes proteínas de la misma secuencia de ADN. Trabaja en el Instituto Profesor Koch Institute for Integrative Cancer Research, Instituto Tecnológico de Massachusetts (MIT), Cambridge, MA, EE. UU.

Author: World Bank
Publisher: World Bank Publications
ISBN:
Category : Business & Economics
Languages : en
Pages : 468

Get Book Here

Book Description
This edition of the World Bank has been revised and expanded by the Terminology Unit in the Languages Services Division of the World Bank in collaboration with the English, Spanish, and French Translation Sections. The Glossary is intended to assist the Bank's translators and interpreters, other Bank staff using French and Spanish in their work, and free-lance translator's and interpreters employed by the Bank. For this reason, the Glossary contains not only financial and economic terminology and terms relating to the Bank's procedures and practices, but also terms that frequently occur in Bank documents, and others for which the Bank has a preferred equivalent. Although many of these terms, relating to such fields as agriculture, education, energy, housing, law, technology, and transportation, could be found in other sources, they have been assembled here for ease of reference. A list of acronyms occurring frequently in Bank texts (the terms to which they refer being found in the Glossary) and a list of international, regional, and national organizations will be found at the end of the Glossary.